In prostate cancer, upregulation of p22phox was also reported to activate PI3K/Akt pathway and extracellular signal-regulated kinase 1/2 (ERK1/2) pathway and subsequently induce HIF-1α via ROS signaling [16]. Here, HIF1A is linked to prostate carcinoma.